FORM 4
[ X ] Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).         
UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP OF SECURITIES
                                                                                  
OMB APPROVAL
OMB Number: 3235-0287
Estimated average burden
hours per response... 0.5
                      
Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934 or Section 30(h) of the Investment Company Act of 1940
                      

1. Name and Address of Reporting Person *

Schuetz Thomas J. 		2. Issuer Name and Ticker or Trading Symbol

Relypsa Inc [ RLYP ] 		5. Relationship of Reporting Person(s) to Issuer (Check all applicable)

__ X __ Director                      _____ 10% Owner
_____ Officer (give title below)      _____ Other (specify below)
(Last)          (First)          (Middle)

C/O RELYPSA, INC., 100 CARDINAL WAY 		3. Date of Earliest Transaction (MM/DD/YYYY)

9/1/2016
(Street)

REDWOOD CITY, CA 94063
(City)        (State)        (Zip)
4. If Amendment, Date Original Filed (MM/DD/YYYY)

 
6. Individual or Joint/Group Filing (Check Applicable Line)

_ X _ Form filed by One Reporting Person
___ Form filed by More than One Reporting Person

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1.Title of Security
(Instr. 3) 		2. Trans. Date 2A. Deemed Execution Date, if any 3. Trans. Code
(Instr. 8) 		4. Securities Acquired (A) or Disposed of (D)
(Instr. 3, 4 and 5) 		5. Amount of Securities Beneficially Owned Following Reported Transaction(s)
(Instr. 3 and 4) 		6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 7. Nature of Indirect Beneficial Ownership (Instr. 4)
Code V Amount (A) or (D) Price
Common Stock   9/1/2016     U (1)    33962   D $32.00   2250   D    
Common Stock   9/1/2016     D (2)    2250   D $32.00   0   D    

Table II - Derivative Securities Beneficially Owned ( e.g. , puts, calls, warrants, options, convertible securities)
1. Title of Derivate Security
(Instr. 3) 		2. Conversion or Exercise Price of Derivative Security 3. Trans. Date 3A. Deemed Execution Date, if any 4. Trans. Code
(Instr. 8) 		5. Number of Derivative Securities Acquired (A) or Disposed of (D)
(Instr. 3, 4 and 5) 		6. Date Exercisable and Expiration Date 7. Title and Amount of Securities Underlying Derivative Security
(Instr. 3 and 4) 		8. Price of Derivative Security
(Instr. 5) 		9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4) 10. Ownership Form of Derivative Security: Direct (D) or Indirect (I) (Instr. 4) 11. Nature of Indirect Beneficial Ownership (Instr. 4)
Code V (A) (D) Date Exercisable Expiration Date Title Amount or Number of Shares
Stock Option (Right to Buy)   $4.65   9/1/2016     D         6976      (2) 9/28/2020   Common Stock   6976     (2) 0   D    
Stock Option (Right to Buy)   $4.65   9/1/2016     D         581      (2) 11/29/2020   Common Stock   581     (2) 0   D    
Stock Option (Right to Buy)   $4.65   9/1/2016     D         1744      (2) 3/30/2021   Common Stock   1744     (2) 0   D    
Stock Option (Right to Buy)   $4.65   9/1/2016     D         872      (2) 6/8/2021   Common Stock   872     (2) 0   D    
Stock Option (Right to Buy)   $3.96   9/1/2016     D         15697      (2) 9/13/2021   Common Stock   15697     (2) 0   D    
Stock Option (Right to Buy)   $3.96   9/1/2016     D         9011      (2) 9/27/2022   Common Stock   9011     (2) 0   D    
Stock Option (Right to Buy)   $7.40   9/1/2016     D         10140      (2) 7/23/2023   Common Stock   10140     (2) 0   D    
Stock Option (Right to Buy)   $23.96   9/1/2016     D         3828      (2) 6/18/2024   Common Stock   3828     (2) 0   D    
Stock Option (Right to Buy)   $35.79   9/1/2016     D         4500      (3) 6/3/2025   Common Stock   4500     (3) 0   D    
Stock Option (Right to Buy)   $17.00   9/1/2016     D         4500      (2) 6/20/2026   Common Stock   4500     (2) 0   D    

Explanation of Responses:
( 1)  Pursuant to the terms of the Agreement and Plan of Merger, dated as of July 20, 2016 (the "Merger Agreement"), by and among the Issuer, Galencia AG, a public limited company existing under the laws of Switzerland ("Parent"), and Vifor Pharma USA Inc., a Delaware corporation and an indirect wholly owned subsidiary of Parent, on September 1, 2016, shares disposed of in exchange for cash consideration of $32.00 per share, without interest, subject to any applicable withholding taxes.
( 2)  Pursuant to the terms of the Merger Agreement, on September 1, 2016, each award of restricted stock units and stock options was cancelled in exchange for the right to receive $32.00 per share in cash less any applicable withholding taxes and in the case of stock options, less the applicable exercise price.
( 3)  Pursuant to the terms of the Merger Agreement, on September 1, 2016, the stock option was cancelled and no cash payment was made as the exercise price exceeded $32.00 per share.

Reporting Owners
Reporting Owner Name / Address
Relationships
Director 10% Owner Officer Other
Schuetz Thomas J.
C/O RELYPSA, INC.
100 CARDINAL WAY
REDWOOD CITY, CA 94063 		X



Signatures
/s/ Ronald A. Krasnow, as Attorney-in-Fact for Thomas J. Schuetz 9/2/2016
** Signature of Reporting Person Date


Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4(b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations. See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB control number.
RELYPSA INC (NASDAQ:RLYP)
Historical Stock Chart
From Oct 2024 to Nov 2024 Click Here for more RELYPSA INC Charts.
RELYPSA INC (NASDAQ:RLYP)
Historical Stock Chart
From Nov 2023 to Nov 2024 Click Here for more RELYPSA INC Charts.